Lilly Will Test Obesity Drugs on Addiction, CEO Says [JfBbl1o-a9t]

Eli Lilly & Co. will begin studies to see if its blockbuster weight-loss medicines can also be used to treat addictive behaviors like alcohol abuse, smoking and drug addiction, Chief Executive Officer Dave Ricks said. These medicines can be useful for other things we don’t think about connected to weight,” Ricks said during an interview with David Rubenstein at a meeting of the Economics Club in Washington, DC. -------- More on Bloomberg Television and Markets Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance: Visit for business news & analysis, up-to-the-minute market data, features, profiles and more. Connect with Bloomberg Television on: X: Facebook: Instagram: Connect with Bloomberg Business on: X: Facebook: Instagram: TikTok: Reddit: LinkedIn: More from Bloomberg: Bloomberg Radio: Bloomberg Surveillance: Bloomberg Politics: Bloomberg Originals: Watch more on YouTube: Bloomberg Technology: Bloomberg Originals: Bloomberg Quicktake: Bloomberg Espanol: Bloomberg Podcasts: #full bar weight loss gummies #proton keto acv gummies amazon